Researchers
Bila, Jelena
Date issued
Date issued - custom
| Issue Date | Title | Author(s) | Type | М-cat. |
|---|---|---|---|---|
| 2023 | Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network (✓) | Ludwig, Heinz; ...; Bila, Jelena S.   ; ...; (broj koautora 29) | Article | 21aM21a |
| 2022 | Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (✓) | Terpos, Evangelos; ...; Bila, Jelena S. ; ...; (broj koautora 23) | Article | 21aM21a |
| 2022 | Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review (✓) | Jovićević, Vanja; Bila, Jelena S. ; Mesaroš, Šarlota T. ; Pekmezović, Tatjana D ; Drulović, Jelena S. | Article | 23M23 |
| 2021 | Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases (✓) | Gerhardt, Kristin; ...; Sretenović, Aleksandra M.; ...; Todorović, Milena R. ; Bila, Jelena S. ; ...; Vučinić, Vladan | Article | 21M21 |
| 2021 | Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group (✓) | Bila, Jelena S. ; Katodritou, Eirini; Guenova, Margarita; Basic-Kinda, Sandra; Coriu, Daniel; Dapcevic, Milena; Ibricevic-Balic, Lejla; Ivanaj, Arben; Karanfilski, Oliver; Zver, Samo;
Beksac, Meral; Terpos, Evangelos; Dimopoulos, Meletios Athanassios;
| Article | 21M21 |
| 2021 | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial (✓) | Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S. ; ...; (broj koautora 23) | Article | 21aM21a |
| 2020 | A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome (✓) | Beksac, Meral; Seval, Guldane Cengiz; Kanellias, Nicholas; Coriu, Daniel; Rosinol, Laura; Ozet, Gulsum; Goranova-Marinova, Vesselina; Unal, Ali; Bila, Jelena S. ; Ozsan, Hayri;
Ivanaj, Arben; Ibričević-Balić, Lejla; Kastritis, Efstathios; Blade, Joan; Dimopoulos, Meletios Athanasios;
| Article | 21aM21a |
| 2020 | Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants (✓) | Todorović-Balint, Milena ; Bila, Jelena ; Balint, Bela ; Jeličić, Jelena ; Đunić, Irena ; Antić, Darko ; Kraguljac-Kurtović, Nada ; Vujić, Dragana ; Mihaljević, Biljana | Article | 23M23 |
| 2020 | Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial | Grosicki, Sebastian; ...; Bila, Jelena S ; ...; (broj, koautora 58) | Article | 21aM21a |
| 2019 | Ultrastructural and morphometric analysis of enlarged platelets in congenital isolated asplenia (✓) | Marković, Olivera ; Martinović, Tamara ; Ćirić, Darko ; Trpinac, Dušan ; Čemerikić-Martinović, Vesna; Bumbaširević, Vladimir ; Bila, Jelena ; Marisavljević, Dragomir ; Kravić-Stevović, Tamara | Article | 23M23 |
| 2018 | Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities (✓) | Antic, Darko A ; Jelicic, Jelena J ; Trajkovic, Goran Z; Todorovic-Balint, Milena R; Bila, Jelena S ; Markovic, Olivera B; Petkovic, Ivan Z ; Nikolic, Vesna; Andjelic, Bosko M; Djurasinovic, Vladislava T;
Sretenovic, Aleksandra M; Smiljanic, Mihailo; Vukovic, Vojin M
; Mihaljevic, Biljana S ; | Article | 22M22 |
| 2018 | 25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it? (✓) | Đurašinović, Vladislava T.; Mihaljević, Biljana ; Šipetić-Grujičić, Sandra B. ; Ignjatović, Svetlana ; Trajković, Goran ; Todorović-Balint, Milena R. ; Antić, Darko ; Bila, Jelena S. ; Anđelić, Boško M.; Jeličić, Jelena J. ;
Vuković, Vojin M.
; Nikolić, Aleksandra M. ; Klek, Stanislaw; | Article | 21aM21a |
| 2017 | Late relapse of Hodgkin's lymphoma - is it different in clinical characteristics and outcome? (✓) | Marković, Olivera B. ; Anđelić, Boško M.; Tarabar, Olivera T. ; Todorović, Milena R. ; Filipović, Branka F. ; Bila, Jelena S. ; Antić, Darko A. ; Marisavljević, Dragomir Ž. ; Stanisavljević, Dejana; Mihaljević, Biljana | Article | 23M23 |
| 2017 | The role of high-dose therapy and autologous stem cell transplantation in the treatment of patients with multiple myeloma | Bila, Jelena ; Jeličić, Jelena; Todorović Balint, Milena; Antić, Darko ; Vujić, Dragana ; Mihaljević, Biljana | Article | 51M51 |
| 2017 | The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients | Bila, Jelena ; Jelicic, Jelena ; Dencic, Fekete Marija; Trajković, Goran ; Sretenovic, Aleksandra; Perunicic, Jovanovic Maja; Antić, Darko ; Mihaljevic, Biljana | Article | 23M23 |
| 2017 | Autologous stem cell transplants - single center standpoints for lymphoma patients (✓) | Todorović-Balint, Milena ; Bálint, Béla ; Bila, Jelena ; Vujić, Dragana ; Anđelić, Boško; Mihaljević, Biljana | Article | 51M51 |
| 2016 | FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma (✓) | Mihaljević, Biljana ; Jelicic, Jelena ; Andjelic, Bosko; Antić, Darko ; Marković, Olivera ; Petkovic, Ivan ; Jovanovic, Maja Perunicic; Trajkovic, Goran; Bila, Jelena ; Djurasinovic, Vladislava;
Sretenovic, Aleksandra; Vukovic, Vojin; Smiljanic, Mihailo; Balint, Milena Todorovic;
| Article | 23M23 |
| 2016 | The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience | Jelicic, Jelena J ; Todorovic-Balint, Milena R; Raicevic, Sava; Ilic, Rosanda; Stanisavljevic, Dejana M ; Bila, Jelena S ; Antic, Darko A ; Balint, Bela J ; Andjelic, Bosko M; Djurasinovic, Vladislava T;
Sretenovic, Aleksandra M; Vukovic, Vojin M
; Mihaljevic, Biljana S ; | Article | 23M23 |
| 2016 | Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses | Todorovic, Balint Milena; Jelicic, Jelena ; Mihaljević, Biljana ; Perić, Jelena ; Stanić, Bojana ; Balint, Bela ; Pejanovic, Nadja; Lucic, Bojana; Tošić, Nataša ; Marjanović, Irena ;
Stojiljković, Maja
; Karan-Đurašević, Teodora ; Perisic, Ognjen; Rakocevic, Goran ; Popovic, Milos; Raicevic, Sava; Bila, Jelena ; Antić, Darko ; Anđelić, Boško; Pavlović, Sonja ; | Article | 21M21 |
| 2016 | Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients (✓) | Antić, Darko ; Milić, Nataša ; Nikolovski, Srđan ; Todorović, Milena ; Bila, Jelena ; Đurđević, Predrag ; Anđelić, Boško; Đurašinović, Vladislava; Sretenović, Aleksandra; Vuković, Vojin ;
Jeličić, Jelena
; Hayman, Suzanne; Mihaljević, Biljana ; | Article | 21M21 |